Life-threatening reversible bone marrow toxicity in a rheumatoid arthritis patient switched from leflunomide to infliximab

Life-threatening reversible bone marrow toxicity in a rheumatoid arthritis patient switched from... Rheumatology 2018;57:1128 doi:10.1093/rheumatology/key094 RHEUMATOLOGY Advance Access publication 28 March 2018 Erratum Life-threatening reversible bone marrow toxicity in a rheumatoid arthritis patient switched from leflunomide to infliximab A. Marchesoni, M. Arreghini, B. Panni, N. Battafarano and L. Uziel Rheumatology 2003;42:193194 doi:10.1093/rheumatology/key051 The doi number listed in the PDF version of this paper has been corrected online, as it contained a typographical error. The correct doi number is 10.1093/rheumatology/key051. Rheumatology, G. Pini Orthopaedic Institute and S. Paolo Hospital, Internal Medicine I, Milan, Italy Correspondence to: A. Marchesoni. E-mail: marchesoni@g-pini.unimi.it The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com Downloaded from https://academic.oup.com/rheumatology/article-abstract/57/6/1128/4955855 by Ed 'DeepDyve' Gillespie user on 20 June 2018 ERRATUM http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Rheumatology Oxford University Press

Life-threatening reversible bone marrow toxicity in a rheumatoid arthritis patient switched from leflunomide to infliximab

Free
1 page

Loading next page...
1 Page
 
/lp/ou_press/life-threatening-reversible-bone-marrow-toxicity-in-a-rheumatoid-5ds4eR5HTr
Publisher
Oxford University Press
Copyright
© The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com
ISSN
1462-0324
eISSN
1462-0332
D.O.I.
10.1093/rheumatology/key094
Publisher site
See Article on Publisher Site

Abstract

Rheumatology 2018;57:1128 doi:10.1093/rheumatology/key094 RHEUMATOLOGY Advance Access publication 28 March 2018 Erratum Life-threatening reversible bone marrow toxicity in a rheumatoid arthritis patient switched from leflunomide to infliximab A. Marchesoni, M. Arreghini, B. Panni, N. Battafarano and L. Uziel Rheumatology 2003;42:193194 doi:10.1093/rheumatology/key051 The doi number listed in the PDF version of this paper has been corrected online, as it contained a typographical error. The correct doi number is 10.1093/rheumatology/key051. Rheumatology, G. Pini Orthopaedic Institute and S. Paolo Hospital, Internal Medicine I, Milan, Italy Correspondence to: A. Marchesoni. E-mail: marchesoni@g-pini.unimi.it The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com Downloaded from https://academic.oup.com/rheumatology/article-abstract/57/6/1128/4955855 by Ed 'DeepDyve' Gillespie user on 20 June 2018 ERRATUM

Journal

RheumatologyOxford University Press

Published: Mar 28, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off